Clinical Trial Update: Phosphodiesterase Inhibitors, Pentoxifylline, as Adjunctive Therapy in Patients With Ulcerative Colitis. [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating pentoxifylline as an adjunctive therapy for ulcerative colitis, currently recruiting at Tanta University.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• Pentoxifylline (pentoxifylline)

Snippet

Sponsor: Tanta University | Conditions: Inflammatory Bowel Diseases | Phase 2 | Status: RECRUITING